Charles River Laboratories International, Inc.
Location
Massachusetts
Founded
1947-02-28
Website
Risk Signals
1058 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Charles River Laboratories International, Inc.
Live alerts from global media, monitored by Business Radar
2024-09-21 (bioprocessintl.com)
Charles River and Ori Biotech collaborate on CAR-T production
Charles River and Ori Biotech collaborate on CAR-T production
Read more
2024-06-06 (bldup.com)
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville
Read more
2023-10-23 (yahoo.com)
Charles River (CRL) Offers Access to Preclinical Cancer Research
Charles River (CRL) contributes to 84 percent of the FDA-approved cancer medicines and provides partners with 16 oncology prospects.
Read more
2023-09-25 (bioprocessintl.com)
Charles River lauds Apollo testing tech at BPI East
Charles River says its Apollo platform gives drug developers direct access to study data, milestones, documents, and program planning tools.
Read more
2022-11-28 (barrons.com)
Charles River Laboratories Opens Contract Vivarium Space in Chicago, Enhancing Access to AAALAC-Accredited, Turnkey Research Program
We've detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. We've detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. We've detected you are on Internet Explorer. For the best
Read more
2021-03-01 (wilmingtonapple.com)
BUSINESS BRIEF: Charles River Labs Announces Strategic Partnership With Kibur Medical To Advance Preclinical Oncology Studies
Charles River will offer exclusive access to its implantable microdevice (IMD) for in vivo preclinical oncology studies.
Read more
2019-12-12 (contractpharma.com)
Charles River Provides Access To Cosmic Antibody Library
Expanded antibody library launched by Distributed Bio aims to expedite the drug discovery process
Read more
(2news.com)
Charles River Laboratories Donates $25,000 to High School Health Science Programs
Charles River Laboratories, Partners in Education with Education Alliance, will present $25,000 to support health science programs in the Washoe County School District.
Read more
(nature.com)
A scalable, reproducible platform for reprogrammed human cells
Reprogrammable human cells hold great promise in disease modelling and drug discovery. A new platform for human iPSC-derived cells could help researchers finally realize it.
Read more